Please login to the form below

Not currently logged in
Email:
Password:

ABPI names latest Code breaches

Bayer Healthcare, Chiesi and Eli Lilly and Company have been called out for breaches of the Association of the British Pharmaceutical Industry's Code of Practice, while Bayer Schering Pharma has been publicly reprimanded

Bayer Healthcare, Chiesi and Eli Lilly and Company have been named in advertisements for breaches of the Association of the British Pharmaceutical Industry's (ABPI) Code of Practice, while Bayer Schering Pharma has been publicly reprimanded.

Bayer Healthcare, Chiesi, Eli Lilly were found to have breached Clause 2 of the ABPI Code of Practice - administered by the Prescription Medicines Code of Practice Authority (PMCPA) - bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Meanwhile Bayer Schering Pharma has been reprimanded for failing to include prescribing information.

The breaches will be highlighted in advertisements in the medical, pharmaceutical and nursing press.

The PMCPA May Code of Practice Review (PDF) has further information on the breaches of the Code.

31st May 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics